Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia · Delayed Price · Currency is AUD 11.21
-0.20 (-1.75%)
Feb 26, 2026, 2:19 PM AEST
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 572.79 million as of February 25, 2026. Its market cap has increased by 1.94% in one year.
Market Cap
572.79M
Enterprise Value
349.21M
Revenue
95.02M
Ranking
n/a
PE Ratio
15.89
Stock Price
11.21
Market Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 572.79M, an increase of 10,861.10%. That is a compound annual growth rate of 20.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 572.79M | -8.43% |
| Dec 31, 2025 | 625.50M | 3.84% |
| Dec 31, 2024 | 602.36M | -24.90% |
| Dec 29, 2023 | 802.04M | -25.09% |
| Dec 30, 2022 | 1.07B | -20.36% |
| Dec 31, 2021 | 1.34B | 21.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuren Pharmaceuticals | 1.55B |
| PYC Therapeutics | 1.40B |
| Clarity Pharmaceuticals | 1.34B |
| Opthea | 738.77M |
| Immutep | 567.38M |
| Racura Oncology | 425.10M |
| Dimerix | 267.18M |
| Orthocell | 252.32M |